|
|
|
|
| LEADER |
02957nam a2200397 u 4500 |
| 001 |
EB001839875 |
| 003 |
EBX01000000000000001003864 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
180702 r ||| eng |
| 020 |
|
|
|a 9780309373234
|
| 020 |
|
|
|a 0309373239
|
| 100 |
1 |
|
|a Norris, Sheena M. Posey
|e [author]
|
| 245 |
0 |
0 |
|a Financial incentives to encourage development of therapies that address unmet medical needs for nervous system disorders
|h Elektronische Ressource
|b workshop summary
|c Sheena M. Posey Norris, Evelyn Strauss, Christopher DeFeo, and Clare Stroud, rapporteurs ; Forum on Neuroscience and Nervous System Disorders, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
|
| 260 |
|
|
|a Washington, D.C.
|b National Academies Press
|c 2015, 2015
|
| 300 |
|
|
|a 1 PDF file (xiv, 114 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Central Nervous System Agents / economics
|
| 653 |
|
|
|a Private Sector / economics
|
| 653 |
|
|
|a Drug Discovery / economics
|
| 653 |
|
|
|a Financial Support
|
| 653 |
|
|
|a Nervous System Diseases / economics
|
| 653 |
|
|
|a Nervous System Diseases / drug therapy
|
| 700 |
1 |
|
|a Strauss, Evelyn
|e [author]
|
| 700 |
1 |
|
|a De Feo, Christopher Joseph
|e [author]
|
| 700 |
1 |
|
|a Stroud, Clare
|e [author]
|
| 710 |
2 |
|
|a Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs for Nervous System Disorders (Workshop) (2015, Washington, D.C.)
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.)
|b Forum on Neuroscience and Nervous System Disorders
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.)
|b Forum on Drug Discovery, Development, and Translation
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 500 |
|
|
|a Title from PDF title page
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK304435
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
|
|a 330
|
| 520 |
|
|
|a The Institute of Medicine (IOM) Forum on Neuroscience and Nervous System Disorders, in collaboration with the IOM Forum on Drug Discovery, Development, and Translation, convened a workshop on January 20-21, 2015, to explore policy changes that might increase private sector investment in research and development innovation that fills unmet medical needs for central nervous system (CNS) disorders. Workshop participants strategized about how to incentivize companies to fortify their CNS drug development programs, shrinking obstacles that currently deter ventures. Representatives from academia, government agencies, patient groups, and industry gathered to share information and viewpoints, and to brainstorm about budget-neutral policy changes that could help widen the pipeline toward drugs that address unmet needs for CNS disorders. This report summarizes the presentations and discussion of the workshop
|